ConductScience.org, home

Paper37550801

ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.

Scott E and 41 others. J Pathol, 2023. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. Papers, record 37550801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37550801

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
PubMed
Journal
J Pathol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
5.56
iCite
Revised in PubMed
2023-08-31
PubMed

Authors42

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scott EEmmahttps://orcid.org/0000-0002-5358-5132
2Archer Goode EEmily
3Garnham RRebecca
4Hodgson KKirsty
5Orozco-Moreno MMargarita
6Turner HHelen
7Livermore KKaren
8Putri Nangkana KKyla
9Frame FMFiona M
10Bermudez AAbel
11Jose Garcia Marques FFernando
12McClurg ULUrszula L
13Wilson LLaura
14Thomas HHuw
15Buskin AAdriana
16Hepburn AAnastasia
17Duxfield AAdam
18Bastian KKayla
19Pye HHayley
20Arredondo HMHector M

Source PubMed

See all 42 authorsDownload CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SialyltransferasesMajor topic
Prostatic NeoplasmsMajor topic
Male
Humans
Glycosylation
Polysaccharides
United Kingdom
beta-D-Galactoside alpha 2-6-Sialyltransferase
Antigens, CD

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Department of HealthUnited KingdomPubMed

Source PubMed

Download CSV of grants

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42714773Validating the biological origin of in vivo fractional intracellular volume from VERDICT-MRI in the prostate.Eur Radiol Exp2026https://conductscience.org/library/papers/42714773PubMed
42647183Sulfonylurea Bioisosteres of Sulfonic Acid in JFD 00458-Based ST6GAL1 Inhibitors Enhance Membrane Permeability.ChemMedChem2026https://conductscience.org/library/papers/42647183PubMed
42645226ST6GAL1 Is a Functional Regulator of UVA-Induced Photoaging in Human Dermal Fibroblasts.Cells2026https://conductscience.org/library/papers/42645226PubMed
42642385Enzymatic activity-independent NANS stabilizes LATS2 to drive growth and therapeutic resistance in HR+/HER2- breast cancer.Nat Commun2026https://conductscience.org/library/papers/42642385PubMed
42541248Aberrant sialylation in cancer: From molecular mechanisms to potential therapeutics.Genes Dis2026https://conductscience.org/library/papers/42541248PubMed
42443559Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis.Br J Cancer2026https://conductscience.org/library/papers/42443559PubMed
42373231Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 Overexpression Abrogates ST6GAL1 Mediated Rectal Cancer Chemoradiation Resistance.Cancer Genomics Proteomics2026https://conductscience.org/library/papers/42373231PubMed
42315913The glycobiology of prostate cancer: an update.Oncogene2026https://conductscience.org/library/papers/42315913PubMed
42291429N-glycosylation alterations in expressed prostatic secretions: exploring liquid biopsy biomarkers for prostate cancer diagnosis and disease progression.PeerJ2026https://conductscience.org/library/papers/42291429PubMed
42132142Tissue-specific factors that govern the sialoglycan-Siglec axis in cancer.Biosci Rep2026https://conductscience.org/library/papers/42132142PubMed
41737773Machine Learning-Based Sialylation-Associated Gene Signature Predicts Prognosis and Immune Landscape in Hepatocellular Carcinoma: Validation via Multi-Omics Analysis and in vitro Assays.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/41737773PubMed
41718984Golgi Drivers of Cancer.Subcell Biochem2026https://conductscience.org/library/papers/41718984PubMed
41651427Sialic acids modulate immune responses in cancer: Therapeutic opportunities.J Biol Chem2026https://conductscience.org/library/papers/41651427PubMed
41651416Writers and readers of sialylation in immunoregulation in cancer.J Biol Chem2026https://conductscience.org/library/papers/41651416PubMed
41584035Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities.J Cancer2026https://conductscience.org/library/papers/41584035PubMed
41241472Spatial atlasing of N-glycosylation in healthy control and clear cell renal cell carcinoma tissues linked with immune checkpoint inhibition response by MALDI mass spectrometry imaging.Anal Chim Acta2025https://conductscience.org/library/papers/41241472PubMed
41228299Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/41228299PubMed
41224336The relationship of ST6GAL1 with clinicopathological and prognostic factors in breast carcinomas.Saudi Med J2025https://conductscience.org/library/papers/41224336PubMed
41217711ST6GAL1-mediated sialylation inhibits the antitumor immune response in colorectal cancer.Cell Oncol (Dordr)2025https://conductscience.org/library/papers/41217711PubMed
41154604Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics.Biomolecules2025https://conductscience.org/library/papers/41154604PubMed

See all 43 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GPHA2170589PubTator's text mininghttps://conductscience.org/library/genes/170589NCBI Gene
IGKV3D-2528873PubTator's text mininghttps://conductscience.org/library/genes/28873NCBI Gene
IGKV6-2128906PubTator's text mininghttps://conductscience.org/library/genes/28906NCBI Gene
ST6GAL16480PubTator's text mininghttps://conductscience.org/library/genes/6480NCBI Gene
ST6GAL284620PubTator's text mininghttps://conductscience.org/library/genes/84620NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37550801

GET https://conductscience.org/api/papers/v1/37550801/authors?page=2